Norepinephrine in threat prediction and PTSD

Determining what the neural substrate of anxiety is will be fundamental to understanding and thus treating psychiatric illness. However, more precise definition of anxiety is needed to develop potential circuit therapeutics for psychiatric disorders. Anxiety can be framed as a state of threat avoidance. Threats, and the brain states they create, exist on a continuum from very imminent to very distant and dealing with different kinds of threats may distinguish subtypes of anxiety behaviors. A critical challenge is to identify the neural mechanisms that enable cognitive and affective information to be combined and utilized in emotional learning. The primary objective of this research is to elucidate the role of norepinephrine (NE) in encoding threat predictive signals within the frontal cortex and its subsequent impact on fear learning and emotional processing. This project will undertake a comprehensive examination of the spatiotemporal dynamics of noradrenergic signals in response to threat cues, aiming to unravel the microcircuit and biochemical mechanisms influenced by NE release. Our approach integrates advanced imaging techniques, such as two- photon calcium imaging and optogenetics, to observe the activity of noradrenergic neurons and their networks in real time. This will allow for an unprecedented examination of the temporal and spatial patterns of NE release and its effect on neural circuitry. Additionally, pharmacological interventions will be employed to manipulate NE levels, providing insights into its role in modulating fear responses and emotional processing. The broader impact of this research lies in its potential to significantly advance our understanding of the neurobiological underpinnings of fear and anxiety disorders. By dissecting the NE system's role in threat prediction, the findings could pave the way for novel therapeutic approaches targeting NE modulation in conditions like PTSD and generalized anxiety disorder. This research holds promise not only for enhancing our fundamental knowledge of the brain's response to fear and threat but also for improving public health by informing the development of more effective treatments for anxiety-related disorders. Project Number: 1I01BX006908-01A1 | Fiscal Year: 2025 | NIH Institute/Center: Veterans Affairs (VA) | Principal Investigator: Alfred Kaye | Institution: VA CONNECTICUT HEALTHCARE SYSTEM, WEST HAVEN, CT | Activity Code: I01 | Study Section: Special Emphasis Panel[ZRD1 MHBA-U (01)] View on NIH RePORTER: https://reporter.nih.gov/project-details/11187309